Nepal Poised To Start HPV Vaccination To Prevent Cervical Cancer, Awaiting GAVI
As Dipak Subedi was organizing a vaccination programme against the human papillomavirus (HPV) in the city of Bharatpur in Chitwan district of southern Nepal he was getting phone calls from neighbouring districts asking if he had extra doses available — people were willing to travel for hours to get their girls vaccinated against HPV, which […] (Source: IPS Inter Press Service - Health)
Source: IPS Inter Press Service - Health - July 31, 2023 Category: International Medicine & Public Health Authors: Marty Logan Tags: Asia-Pacific Gender Headlines Health TerraViva United Nations human papillomavirus (HPV) Source Type: news
What Are Treatments for Recurrent Respiratory Papillomatosis?
Discussion
Human papilloma virus (HPV) is a member of the Papillomaviridae virus family with over a 150 different subtypes. HPV can cause cervical, genital and respiratory tract papillomas. HPV is often benign but can cause anogenital, cervical and head and neck cancers.
Recurrent respiratory papillomatosis (RRP) is uncommon but can cause significant morbidity while awaiting the body’s immune system to respond. There is a juvenile and adult form, and the incidence varies between 2-4/100,000 in the pediatric population. The juvenile form frequently occurs between 3.6-6 years of age and in general the younger the patie...
Source: PediatricEducation.org - July 31, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
A Shot in the Arm Can Prevent Cervical Cancer
Afshan Bhurgri, a cancer survivor, advises women to listen to their bodies and be aware of the symptoms of cervical cancer. Credit: Zofeen Ebrahim/IPSBy Zofeen EbrahimKARACHI, Jul 26 2023 (IPS) “Listen to your body, and if there is anything strange happening, do not ignore it,” is the advice of 57-year-old Afshan Bhurgri, a cancer survivor.
Eight years ago, she was diagnosed with cervical cancer at a time when she was “in a good place” in life. Her kids were grown up, and she had more time to herself. A fitness freak, the schoolteacher’s daily routine included going to the gym daily. “I joined a creative writin...
Source: IPS Inter Press Service - Health - July 26, 2023 Category: International Medicine & Public Health Authors: Zofeen Ebrahim Tags: Asia-Pacific Development & Aid Editors' Choice Featured Gender Headlines Health Human Rights Humanitarian Emergencies Sustainable Development Goals TerraViva United Nations Women's Health Education Cannot Wait (ECW) IPS UN Bureau Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Investor Update - June 13, 2023 Category: Pharmaceuticals Source Type: news
Roche awarded WHO prequalification for the cobas ® HPV test, increasing access to cervical cancer screening tools in low and lower-middle income countries
Every year, over 600,000 women worldwideare diagnosed with cervical cancer and over 340,000 die from this preventable disease, caused by infection with human papillomavirus (HPV). Nine out of 10 women who die from cervical cancer live in low- and lower-middle income countries (LMICs).1WHO prequalification enables LMICs to use thecobas® HPV test in their national cervical cancer elimination programs, increasing access to the patients who need it most.Establishing screening programs helps prevent and detect cervical cancer, which is especially important in areas with limited healthcare resources where patientsare often diag...
Source: Roche Media News - June 13, 2023 Category: Pharmaceuticals Source Type: news
Harald zur Hausen, 87, Nobelist Who Found Cause of Cervical Cancer, Dies
When he proposed that the human papillomavirus caused cervical cancer, he was ridiculed. He persevered, and today a vaccine exists. (Source: NYT Health)
Source: NYT Health - June 9, 2023 Category: Consumer Health News Authors: Emily Anthes Tags: zur Hausen, Harald Deaths (Obituaries) Sexually Transmitted Diseases Cervical Cancer Human Papillomavirus (HPV) Vaccination and Immunization Nobel Prizes Research Source Type: news
Military members half as likely as civilians to receive HPV vaccine
Active-duty military and veterans are twice as likely as civilians to develop cancers associated with human papillomavirus, or HPV. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - May 28, 2023 Category: Consumer Health News Authors: Erin Blakemore Source Type: news
No Access to Routine Healthcare Biggest Barrier to HPV Vaccination
(MedPage Today) -- BALTIMORE -- People with access to routine healthcare were more likely to have received human papillomavirus (HPV) vaccination compared with those who did not have this access, a retrospective analysis of National Health and... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - May 25, 2023 Category: American Health Source Type: news
More Parents Citing Safety as Reason for HPV Vaccine Hesitancy
TUESDAY, May 23, 2023 -- The proportion of parents citing " safety or side effects " as a reason for human papillomavirus (HPV) vaccine hesitancy for their adolescent children increased from 2010 to 2018, according to a study published online May 23... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 23, 2023 Category: Pharmaceuticals Source Type: news
Parents' Mistrust of HPV Vaccine May Be Growing
TUESDAY, May 23, 2023 -- It was a no-brainer for New York City mom Jen L. when a pediatrician suggested that she vaccinate her two sons against human papillomavirus (HPV). “Before my kids were eligible for the vaccine, I had read up on it to learn... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 23, 2023 Category: General Medicine Source Type: news
An African Country Faces Challenges to Protect Girls From HPV
Almost all cervical cancer deaths now occur in developing countries. Tanzania is trying to inoculate girls against the virus that causes the disease — nearly 20 years after rich countries began offering the shot. (Source: NYT Health)
Source: NYT Health - May 23, 2023 Category: Consumer Health News Authors: Stephanie Nolen Tags: Sexually Transmitted Diseases Vaccination and Immunization Cervical Cancer Rumors and Misinformation Human Papillomavirus (HPV) Developing Countries Gardasil (Vaccine) Gavi, the Vaccine Alliance Tanzania your-feed-healthcare your-feed- Source Type: news
One Dose of HPV Vaccine Prevents Infection for at Least Three Years
Protection may last even longer, scientists reported. The finding may be a boon to low-income countries, where cervical cancer takes an enormous toll. (Source: NYT Health)
Source: NYT Health - May 2, 2023 Category: Consumer Health News Authors: Apoorva Mandavilli Tags: Vaccination and Immunization Human Papillomavirus (HPV) Women and Girls Cervical Cancer Viruses Preventive Medicine Kenya Source Type: news
Indian vaccine market to reach valuation of Rs 252 bn by 2025: Jitendra Singh
Singh said that the world is now increasingly realising India's superlative capacities in preventive healthcare and we are now in the process of developing several other vaccines in the series. Recently after the first DNA vaccine, the first nasal vaccine has also been successfully manufactured and another vaccine related to Human Papillomavirus (HPV) which has helped in the prevention of cervical cancer has also been developed. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 30, 2023 Category: Pharmaceuticals Source Type: news
Merck Reverses Higher As Keytruda, Gardasil Outplay Covid Decline; Bristol Shares Dip
topped Wall Street's first-quarter forecasts Thursday while Bristol Myers Squibb (BMY) delivered a mixed performance. Merck stock swung to a gain while and BMY stock toppled. X Cancer treatments Keytruda and Opdivo helped drive growth for Merck and Bristol, respectively. Keytruda sales continued…#bristolmyerssquibb #bmy #xcancer #keytrudaandopdivo #merck #bristol #keytruda #opdivo #gardasil #bristolmyers (Source: Reuters: Health)
Source: Reuters: Health - April 29, 2023 Category: Consumer Health News Source Type: news
Africa: 'Vaccinate Against Deadly Diseases Including Covid-19'
[ADAPT] African Vaccination Week is a crucial reminder of the life-saving power of vaccines. From COVID-19 to polio, diphtheria, tetanus, hepatitis B, influenza, rotavirus, measles, and the human papillomavirus (HPV), vaccines offer protection against deadly diseases. With this week falling on the last week of April, there is no better time to prioritize vaccination. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - April 25, 2023 Category: African Health Source Type: news
